Pharmidex is an AAALAC-accredited, UK-based CRO founded in 2002. 
We provide high-quality, cost-effective, flexible and rapid solutions in drug metabolism and pharmacokinetics (DMPK), bioanalysis (non-GLP/GLP/GCP), toxicology (non-GLP/GLP), histology, clinical chemistry, hematology, and in vitro ADME. 

Pharmidex also offers in silico modelling and efficacy models supporting oncology, CNS, respiratory, stroke, autoimmune, and metabolic disease programs.

We work with over 250 global clients, including medical charities, academic groups, biotech, and pharma, and have undertaken over 15,000 studies. In addition to our fee-for-service offering, Pharmidex actively seeks collaboration opportunities in grant-funded projects. To date, we have successfully participated in over 30 collaborative grant-funded projects, partnering with more than 167 global collaborators.

Biotechnology

Clinical Trials

Health Care

Life Sciences

Pharmaceutical

Pharmidex

The London office focuses on advancing drug development through research and business strategy initiatives.

Pharmidex

Org chart

Teams

Offices